Joint MEB/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing Training Course

Met korting

26/10/20 -
30/10/20

Amsterdam

The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance. Now available in individual Modules.

Overview

This course is designed to provide a strong foundation in all important key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This comprehensive and interactive five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.

It is also possible to register to each of the 4 course modules individually:

• Module 1: Definitions and Methods in Pharmacovigilance
• Module 2: Regulatory Aspects in Pharmacovigilance and Practical Examples
• Module 3: Signal Detection and Management
• Module 4:Risk Management

Target audience

This course will benefit professionals with basic knowledge and experience in Pharmacovigilance or adjacent functions, for example, PV Officers, PV Specialists, PV Experts, PV Coordinators, Heads/Directors/Managers of Regulatory Compliance, Quality or Safety departments.

More information

https://www.diaglobal.org/en/course-listing#q=all/sort=relevance/page=0/region=

Member discount

HollandBIO members are eligible for a 15% discount. To obtain the discount please send your registration form to: basel@diaglobal.org